D. Western Therapeutics Institute, Inc.
Notice of Changes to a Debt Agreement with Financial Covenants
Hedging covenants attached loan agreement amended. Targets are the revolving loan agreements dated April 16, 2010 and June 30, 2022. Changes: keep equity attributable to owners at positive amounts at each fiscal year-end, hold fixed deposits exceeding loan balances. Impact on consolidated results for the 2026 fiscal year is expected to be minor.
Key Figures
- April 16, 2020 revolving loan agreement principal: 100,000 千円
- June 30, 2022 revolving loan agreement principal: 440,000 千円
- End of June 2026 balance: 61,904 千円
AI要約
Performance and Financial Impact
This notice concerns a change to a loan agreement that modifies financial covenants, and the impact on the consolidated results for the year ending December 2026 is expected to be minor. The affected contracts include DW-5LBT and DWR-2206, totaling two agreements. The change maintains the equity portion at fiscal year-end as a positive figure and requires holding fixed deposits sufficient to cover the total loan balance.
Contract Overview and Background
This updates the revolving loan agreements dated April 16, 2020 and June 30, 2022. Counterparty is Mizuho Bank; principal amounts are 100,000 thousand yen and 440,000 thousand yen respectively; no collateral. The effective date of the amended contract is the date of signing, June 30, 2026.
De Westan Therapitecs Institute
Company overview · Stock price · Financial data · All IR
